Investing
1158 Articles
These are not the only top analyst calls impacting share prices this morning, but these are the main calls that…
We are updating our list of tier-one Defensive Stocks since so many of these stocks have run up and since…
Early this week we are running a list of stocks that have been in a turnaround plan, yet the stocks…
James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad…
According to Reuters, OPEC will probably keep oil output at current levels. Reuters writes that a goverment plan to help…
Abbott Labs (ABT) which just launched a new stent product, Xience V, has laid off 1,200 people because of slowness…
Abbot Labs (ABT) is trying to get into the stent business. The market has been dominated by Boston Scientific (BSX)…
Several studies which showed that stents could cause blood clotting in the heart have done significant damage to the revenue…
According to Reuters, BHP Billiton (BHP) will not sell its petroleum division, as had been rumored, to finance a bid…
The markets haven’t fallen apart after yesterday’s 360 point dive on the DJIA, but we are still trading a tad…
Boston Scientific (BSX) did it shareholders a terrible disservice buy buying Guidant in a bidding war with Johnson & Johnson.…
With the markets down so much today on the financial stock fallout after the Citi downgrade/concern and with oil stocks…
"William O’Neill, dean of clinical affairs at University of Miami’sMiller School of Medicine, says stent-patient traffic is beginning topick up…
Shares of Amgen Inc. (NASDAQ:AMGN) are under bit of pressure this morning, although not from any direct news from the…
Johnson & Johnson (JNJ) announced third-quarter sales of $15.0 billion, an increase of 12.7% as compared to the third quarter…
Our top personal finance-related articles today. Your wallet will thank you later.